
Ribociclib Aids First-Line Endocrine Therapy in Premenopausal Patients
Author(s) -
Peter M. Goodwin
Publication year - 2018
Publication title -
oncology times
Language(s) - Uncategorized
Resource type - Journals
eISSN - 1548-4688
pISSN - 0276-2234
DOI - 10.1097/01.cot.0000534140.15592.44
Subject(s) - letrozole , tamoxifen , goserelin , medicine , aromatase inhibitor , anastrozole , oncology , breast cancer , palbociclib , aromatase , clinical endpoint , antiestrogen , cancer , gynecology , metastatic breast cancer , randomized controlled trial